29 Dec 2014
(MENAFN) UAE’s RAK Ceramics, the world’s largest ceramics manufacturer, announced that its subsidy in Bangladesh is planning to sell RAK Pharma, its pharmaceutical interest, as the company proceeds in its plan to offload its asset to focus more on its core business of ceramics production, Emirates 24/7 reported.
RAK Ceramics said that its Bangladesh unit currently has a 55 percent stake in RAK Pharma, with expectations that that company will sell its entire stock of RAK Pharma shares, while the other shares will be sold by minority shareholders, with the entire sale estimated to be valued at USD9.5 million.
“The decision to sell RAK Pharma was taken for two reasons. Firstly, our strategy is to focus on our core activities; tiles, sanitary ware, taps and faucets and tableware. In addition, RAK Pharma is currently a loss-making division so it makes good business sense to sell it at this time,” CEO, RAK Ceramics said.
The RAK Ceramics also said that the Bangladesh unit is planning to increase its capacity of tiles and sanitary ware production in Bangladesh and that the expansion is already underway, and is scheduled to be done in 2015.
28 Jul 2025
BBK discloses its financial results for the half year ended 30th June 2025
20 Jul 2025
CBB approves the transfer of the retail banking operations of HSBC Bank Middle East, Bahrain Branch to BBK
08 Jul 2025
BBK proudly launches the third edition of “Grow” and welcomes 20 Bahraini graduates
03 Jul 2025
BBK hosts executive leadership session on digital assets in collaboration with Rain
02 Jul 2025
BBK launches the largest-ever Al Hayrat Prizes, offering BD 5 million to over 2,000 winners
16 Jun 2025
BBK and CrediMax Offer Exclusive 20% Discount on Turkish Airlines Flights for Cardholders
25 May 2025
BBK strengthens commitment to sports development through strategic partnership with Bahrain Basketball Association
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more